vs

Side-by-side financial comparison of Live Oak Bancshares, Inc. (LOB) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $145.5M, roughly 1.4× Live Oak Bancshares, Inc.). Live Oak Bancshares, Inc. runs the higher net margin — 19.2% vs 6.7%, a 12.5% gap on every dollar of revenue. On growth, Live Oak Bancshares, Inc. posted the faster year-over-year revenue change (18.4% vs 13.6%). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs 7.7%).

Live Oak Bank, a subsidiary of Live Oak Bancshares, Inc., is an American bank. Headquartered in Wilmington, North Carolina, it serves small business owners in all 50 states and was the leading SBA 7(a) lender by dollar volume in 2022.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

LOB vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.4× larger
RGEN
$197.9M
$145.5M
LOB
Growing faster (revenue YoY)
LOB
LOB
+4.7% gap
LOB
18.4%
13.6%
RGEN
Higher net margin
LOB
LOB
12.5% more per $
LOB
19.2%
6.7%
RGEN
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
7.7%
LOB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
LOB
LOB
RGEN
RGEN
Revenue
$145.5M
$197.9M
Net Profit
$27.9M
$13.3M
Gross Margin
52.5%
Operating Margin
9.0%
Net Margin
19.2%
6.7%
Revenue YoY
18.4%
13.6%
Net Profit YoY
187.6%
143.9%
EPS (diluted)
$0.60
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LOB
LOB
RGEN
RGEN
Q1 26
$145.5M
Q4 25
$161.9M
$197.9M
Q3 25
$146.1M
$188.8M
Q2 25
$143.7M
$182.4M
Q1 25
$126.1M
$169.2M
Q4 24
$116.9M
$174.1M
Q3 24
$129.9M
$154.9M
Q2 24
$125.5M
$154.1M
Net Profit
LOB
LOB
RGEN
RGEN
Q1 26
$27.9M
Q4 25
$46.2M
$13.3M
Q3 25
$26.5M
$14.9M
Q2 25
$23.4M
$14.9M
Q1 25
$9.7M
$5.8M
Q4 24
$9.9M
$-30.3M
Q3 24
$13.0M
$-654.0K
Q2 24
$27.0M
$3.3M
Gross Margin
LOB
LOB
RGEN
RGEN
Q1 26
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Operating Margin
LOB
LOB
RGEN
RGEN
Q1 26
Q4 25
38.2%
9.0%
Q3 25
25.0%
8.9%
Q2 25
21.7%
7.6%
Q1 25
10.4%
3.9%
Q4 24
11.3%
-17.7%
Q3 24
13.7%
-5.1%
Q2 24
28.7%
1.0%
Net Margin
LOB
LOB
RGEN
RGEN
Q1 26
19.2%
Q4 25
28.5%
6.7%
Q3 25
18.1%
7.9%
Q2 25
16.3%
8.2%
Q1 25
7.7%
3.4%
Q4 24
8.5%
-17.4%
Q3 24
10.0%
-0.4%
Q2 24
21.5%
2.2%
EPS (diluted)
LOB
LOB
RGEN
RGEN
Q1 26
$0.60
Q4 25
$0.96
$0.24
Q3 25
$0.55
$0.26
Q2 25
$0.51
$0.26
Q1 25
$0.21
$0.10
Q4 24
$0.22
$-0.55
Q3 24
$0.28
$-0.01
Q2 24
$0.59
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LOB
LOB
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$1.3B
$2.1B
Total Assets
$15.3B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LOB
LOB
RGEN
RGEN
Q1 26
Q4 25
$767.6M
Q3 25
$748.7M
Q2 25
$708.9M
Q1 25
$697.2M
Q4 24
$757.4M
Q3 24
$784.0M
Q2 24
$809.1M
Total Debt
LOB
LOB
RGEN
RGEN
Q1 26
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Stockholders' Equity
LOB
LOB
RGEN
RGEN
Q1 26
$1.3B
Q4 25
$1.2B
$2.1B
Q3 25
$1.2B
$2.1B
Q2 25
$1.1B
$2.1B
Q1 25
$1.0B
$2.0B
Q4 24
$999.0M
$2.0B
Q3 24
$1.0B
$2.0B
Q2 24
$961.0M
$2.0B
Total Assets
LOB
LOB
RGEN
RGEN
Q1 26
$15.3B
Q4 25
$15.1B
$2.9B
Q3 25
$14.7B
$2.9B
Q2 25
$13.8B
$2.9B
Q1 25
$13.6B
$2.9B
Q4 24
$12.9B
$2.8B
Q3 24
$12.6B
$2.8B
Q2 24
$11.9B
$2.9B
Debt / Equity
LOB
LOB
RGEN
RGEN
Q1 26
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LOB
LOB
RGEN
RGEN
Operating Cash FlowLast quarter
$25.7M
Free Cash FlowOCF − Capex
$17.6M
FCF MarginFCF / Revenue
8.9%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LOB
LOB
RGEN
RGEN
Q1 26
Q4 25
$158.2M
$25.7M
Q3 25
$62.3M
$48.1M
Q2 25
$49.2M
$28.6M
Q1 25
$-33.0M
$15.0M
Q4 24
$156.8M
$39.2M
Q3 24
$47.4M
$49.3M
Q2 24
$29.5M
$42.2M
Free Cash Flow
LOB
LOB
RGEN
RGEN
Q1 26
Q4 25
$143.5M
$17.6M
Q3 25
$60.6M
$43.4M
Q2 25
$47.8M
$21.5M
Q1 25
$-35.3M
$11.4M
Q4 24
$107.5M
$33.6M
Q3 24
$41.0M
$42.3M
Q2 24
$12.3M
$37.4M
FCF Margin
LOB
LOB
RGEN
RGEN
Q1 26
Q4 25
88.6%
8.9%
Q3 25
41.4%
23.0%
Q2 25
33.3%
11.8%
Q1 25
-28.0%
6.8%
Q4 24
91.9%
19.3%
Q3 24
31.6%
27.3%
Q2 24
9.8%
24.3%
Capex Intensity
LOB
LOB
RGEN
RGEN
Q1 26
Q4 25
9.1%
4.1%
Q3 25
1.2%
2.5%
Q2 25
1.0%
3.9%
Q1 25
1.8%
2.1%
Q4 24
42.2%
3.2%
Q3 24
4.9%
4.5%
Q2 24
13.7%
3.1%
Cash Conversion
LOB
LOB
RGEN
RGEN
Q1 26
Q4 25
3.42×
1.93×
Q3 25
2.35×
3.23×
Q2 25
2.10×
1.92×
Q1 25
-3.39×
2.57×
Q4 24
15.84×
Q3 24
3.64×
Q2 24
1.10×
12.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons